For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Chimera Bioengineering, Inc.

USPTO Granted Patents = 21

% Expired Patents = 19.0

EPO Patents = 2

Forward Citations = 63

Loading Chart...

Loading Chart...

6 inventors (with patents filed for the assignee):

Benjamin Wang (21 out of 26 patents)

Gusti Zeiner (21 out of 29 patents)

Krista McNally (5 out of 5 patents)

4. Scott Dylla (1 out of 1 patent)

5. Eytan Herzig (1 out of 1 patent)

6. Albert Gacerez (1 out of 1 patent)

7. Benjamin Wang (0 patent)

21 patents: Sort by Forward Citations

1. 12576135 - Compositions and Methods for Anti-TnMUC1 Gold CAR T-cells (2026-03-17),

2. 11718929 - Methods for making novel antigen binding domains (2023-08-08),

3. 11648277 - Combination therapy with gold controlled transgenes (2023-05-16),

4. 11572566 - Gold optimized CAR t-cells (2023-02-07),

5. 11535853 - Gold optimized CAR T-cells (2022-12-27),

6. 11530272 - Smart car devices, DE car polypeptides, side CARs and uses thereof (2022-12-20),

7. 11497774 - Coordinating gene expression using RNA destabilizing elements (2022-11-15),

8. 11459572 - Gold optimized CAR T-cells (2022-10-04),

9. 11311577 - Coordinating gene expression using RNA destabilizing elements (2022-04-26),

10. 11110125 - Coordinating gene expression using RNA destabilizing elements (2021-09-07),

11. 11085917 - Methods for making novel antigen binding domains (2021-08-10),

12. 11052111 - Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses (2021-07-06),

13. 10858660 - Gold optimized CAR T-cells (2020-12-08),

14. 10688132 - Coordinating gene expression using RNA destabilizing elements (2020-06-23),

15. 10675305 - Coordinating gene expression using RNA destabilizing elements (2020-06-09),

Chimera Bioengineering, Inc. is a leading biotechnology company focused on the development of groundbreaking therapies for treating genetic diseases. With a multi-disciplinary team of scientists and engineers, we combine cutting-edge gene editing technologies and cellular engineering techniques to create innovative solutions. Our mission is to revolutionize medicine and improve the lives of patients worldwide. Visit our website to learn more about our pioneering research and ongoing projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

21 Patents

#76 in Menlo Park, CA

#3,750 in California

#15,652 in US

#29,854 in the World

Menlo Park, CA, United States of America

Chimera Bioengineering, Inc.

Forward Citations = 63

6 inventors:

Benjamin Wang (21 out of 26 patents)

Gusti Zeiner (21 out of 29 patents)

Krista McNally (5 out of 5 patents)

4. Scott Dylla (1 out of 1 patent)

5. Eytan Herzig (1 out of 1 patent)

Please report any incorrect information to [email protected]

Loading…